News

Join Calidi Biotherapeutics for an Insightful Investor Webcast

Join Calidi Biotherapeutics for an Insightful Investor Webcast

Calidi Biotherapeutics Invites Investors to a Special Webinar

In an exciting opportunity for investors, Calidi Biotherapeutics Inc. (NYSE American: CLDI), a pioneering organization in the biotechnology sector, is hosting an exclusive webinar. This event promises to deliver valuable insights into the company’s groundbreaking work in the field of targeted antitumor virotherapies. It is scheduled to take place at 4:15 p.m. ET, marking an essential occasion for those interested in the future of cancer treatment.

Expert Presentation and Q&A Session

The webinar will be hosted by RedChip Companies and features key personnel from Calidi, including CFO Andrew Jackson and CSO Antonio F. Santidrian, PharmD. PhD. These experts will share in-depth information about Calidi's innovative cell-based delivery systems, designed to significantly enhance the treatment of various cancers.

Overview of Innovative Lead Programs

During the session, the presenters will discuss some of Calidi’s most promising lead programs. This includes CLD-400, which is specifically targeting metastatic cancers, as well as CLD-201 developed for advanced solid tumors, and CLD-101 aimed at high-grade glioma patients. Each program reflects Calidi's commitment to harnessing innovative technologies in the fight against cancer.

Interactive Q&A Opportunity

After the presentations, attendees will have the chance to engage directly with Calidi's leadership team during a live Q&A session. This interactive portion will allow participants to inquire further about the company’s research, development strategies, and future plans, fostering a deeper understanding of Calidi's commitment to advancing cancer therapies.

How to Register

Registering for the webinar is simple and free of charge. Interested individuals can sign up and join in on this informative session. It’s a great opportunity for investors and anyone interested in the latest advancements in cancer treatment.

About Calidi Biotherapeutics

Calidi Biotherapeutics is at the forefront of innovation in the immuno-oncology arena, utilizing its unique approaches to empower the immune system in the fight against cancer. The company develops advanced cell-based platforms that leverage allogeneic stem cells. These cells efficiently carry oncolytic viruses, which serve as a novel therapeutic strategy for treating challenging oncology situations, such as high-grade gliomas and a range of solid tumors.

The Dual Mechanism Approach

Calidi’s robust platform not only aims to deliver oncolytic viruses but also enhances their efficacy and safety for patients. Their preclinical efforts include enveloped virotherapies, designed to address disseminated solid tumors, showcasing a dual action approach to potentially mitigate or even prevent metastatic disease.

Headquarters and Further Information

Calidi Biotherapeutics maintains its headquarters in San Diego, California. With a dedication to advancing cancer therapies, the company is committed to providing innovative solutions in oncology. For anyone interested in learning more about Calidi and its research initiatives, additional information is readily accessible on the company’s official website.

Frequently Asked Questions

What is the primary goal of the Calidi Biotherapeutics webinar?

The primary goal is to share insights into the company's innovative therapies and engage with investors through a Q&A session.

Who are the featured speakers at the webinar?

The webinar will feature CFO Andrew Jackson and CSO Antonio F. Santidrian, who will discuss the company's strategic direction.

What specific programs will be highlighted during the event?

Prominent programs such as CLD-400, CLD-201, and CLD-101 will be discussed in detail.

How can I register for the webinar?

Registration is free and can be completed online through the designated registration link provided by Calidi Biotherapeutics.

Where is Calidi Biotherapeutics headquartered?

The company is headquartered in San Diego, California, focusing on advancing clinical-stage immuno-oncology solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Chery Auto's Bold Green Tech Showcase at 2026 Summit

Updated Category News Views 2

Chery Auto Puts Eco Tech at Front and Center You know, Chery Auto isn't just manufacturing cars anymore—it's shaping an entire lifestyle. For the uninitiated, they’re calling in everyone worth knowing to their headquarters in Wuhu, China, come October 18 through 24. The 2026 Chery International User Summit is kind of a big deal this year with nearly 20 new green...

Continue Reading
PayPal Under Investigation: Legal Battles Intensify

Updated Category News Views 3

A Bumpy Ride for PayPal's Investors Back in 2025, PayPal was beaming about new growth strategies, filling the air with grandiose promises. Fast forward to February 2026, and the script had flipped entirely. Earnings came in nasty and disappointing, particularly in the Branded Checkout front. Adding to the chaos was their CEO unceremoniously taking the high road out the...

Continue Reading
Hainan Airlines' Dedication Keeps It atop Skytrax

Updated Category News Views 5

Fifteen years of soaring high: now that's something worth taking to the bank—or the air. Hainan Airlines has just bagged the SKYTRAX Five-Star Airline rating once again, handed out at this year's World Airline Awards ceremony. When it comes to delivering quality, they're flying high on the charts, landing among the World's Best Airlines Top 10. And in the wild world of...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 7

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
2026 Lantern Festival Shines in Kunshan Amid Tensions

Updated Category News Views 4

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

Continue Reading
Fast Guard Elevates Nationwide Fire Watch Mission

Updated Category News Views 2

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

Continue Reading
China's Tech Success Echoes in Global Living Rooms

Updated Category News Views 4

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

Continue Reading
GAC's Cambodia Plant: A Strategic Manufacturing Shift

Updated Category News Views 3

Setting the Stage for New Industrial Growth On September 17, a milestone was etched in the sands of Cambodia when the GAC Cambodia KD Plant officially flipped the switch. This ain't just another factory throwing doors open; it's a fresh chapter in regional manufacturing power plays. We had some big hitters in attendance, like Cambodian Prime Minister Hun Manet, showing...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 5

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
USPS Rolls Out Christmas Cookie Stamps Nationwide

Updated Category News Views 3

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Developments from Pembroke Property Finance 3 DAC

Updated Category News Views 384

Overview of Pembroke Property Finance 3 DAC Ratings KBRA UK (KBRA) is thrilled to share the assignment of preliminary ratings to six distinct classes of Pembroke Property Finance 3 DAC. This exciting financial structure represents a sizable €343.6 million multi-borrower CMBS securitisation that is secured by an impressive portfolio of 110 loans. These loans are backed...

Continue Reading
Wells Fargo Contributes Over $1 Million for Disaster Relief Efforts

Updated Category News Views 233

Wells Fargo stepped up with over $1 million in disaster relief back when Hurricane Helene tore through the Southeast, showing that a big player can still act when the chips are down. The money was aimed straight at urgent needs like shelter and supplies for those reeling from this storm's wrath. But here's the kicker—traders watching WFC were probably wondering if this...

Continue Reading
Unexpected Rise in China's Services Activity: Caixin PMI Insight

Updated Category News Views 39

Unexpected Growth in China's Services Sector China's services sector has shown impressive growth, exceeding expectations for October. This development comes in light of new stimulus measures implemented by the government, compelling businesses to ramp up their activity. Caixin Services PMI Surprises Economists The private purchasing managers index (PMI) for the services...

Continue Reading
Transformative Journey: Zénabou's Path to Education Inclusion

Updated Category News Views 228

Zénabou's Inspirational Journey Towards Education Inclusion Education is a powerful tool for transformation, especially for children with disabilities. In the Central African Republic, initiatives spearheaded by local and international organizations are opening doors for these children, allowing them to pursue their education. Zénabou, a 14-year-old girl born deaf and...

Continue Reading
Promising Results of Amivantamab in Metastatic Colorectal Cancer

Updated Category News Views 128

Breakthrough in Colorectal Cancer Treatment Recent research highlights the significant potential of amivantamab, particularly when used alongside standard chemotherapy drugs, for treating metastatic colorectal cancer (mCRC). These findings come from an extensive Phase 1b/2 study, which has shown an overall response rate (ORR) of 49 percent among patients who had not...

Continue Reading